INTRODUCTION
============

The term carbon catabolite repression is currently in use to describe the general phenomenon in microorganisms whereby the presence of a carbon source in the medium can repress expression of certain genes and operons, whose gene products are often concerned with catabolism of alternative carbon sources. The mechanisms of carbon catabolite repression in response to rapidly metabolizable carbon sources have been extensively examined in *Escherichia coli* ([@b1],[@b2]). In the vast majority of documented cases, the preferred carbon source is glucose with the famous *E.coli* glucose--lactose diauxie as the classical example. The glucose-mediated catabolite repression, termed glucose repression, is mainly mediated by the proteins of the phosphoenolpyruvate (PEP):sugar phosphotransferase system (PTS). This system consists of sugar-specific PTS permeases, also referred to as enzymes II, and two general PTS proteins, enzyme I and histidine-containing protein (HPr), that participate in the phosphorylation of all PTS-transported carbohydrates. The glucose-specific PTS proteins consist of the soluble enzyme IIA^Glc^ (EIIA^Glc^) and the membrane-bound enzyme IICB^Glc^ (EIICB^Glc^). During translocation of glucose, a phosphoryl group derived from PEP is transferred sequentially along a series of proteins (enzyme I, HPr, EIIA^Glc^ and EIICB^Glc^) to the transported glucose molecule.

Central to carbon catabolite repression is the phosphorylation state of EIIA^Glc^. In the presence of glucose, unphosphorylated EIIA^Glc^ binds and inhibits various proteins involved in uptake and metabolism of non-PTS carbohydrates by a mechanism termed inducer exclusion ([@b1],[@b3]). However, in the absence of glucose, adenylate cyclase is known to be activated to increase the intracellular amount of cAMP, the allosteric effector necessary for the cAMP receptor protein (CRP) to bind efficiently to DNA and activate transcription at more than 100 promoters ([@b4]). A popular model for the regulation of adenylate cyclase activity is that the phosphorylated form of EIIA^Glc^ generated in the absence of glucose stimulates adenylate cyclase activity; thus, glucose transport is presumed to lead to dephosphorylation of IIA^Glc^, resulting in a de-activation of adenylate cyclase and the glucose repression of many genes ([@b1]). Recently, the dephospho-form of EIIA^Glc^ was also shown to interact with FrsA to regulate the flux between respiration and fermentation pathways ([@b5]), supporting importance of EIIA^Glc^ in catabolic regulations.

Expression of the *E.coli sdhCDAB* operon encoding the succinate dehydrogenase complex, the sole membrane-bound enzyme of the tricarboxylic acid (TCA) cycle, has also been known to be regulated in response to carbon supply as well as anaerobiosis ([@b6],[@b7]). Recent study also revealed that a small RNA, RyhB, down-regulates the mRNA level for *sdhCDAB* operon at the post-transcriptional initiation level in response to iron availability ([@b8]). For the anaerobic repression of *sdhCDAB*, two global regulatory circuits were shown to be involved: the ArcB/A two-component system and the Fnr anaerobic regulator modulate *sdhCDAB* expression over a 70-fold range to provide different amounts of enzyme depending on the cells\' needs for energy and carbon intermediates ([@b7],[@b9]). While the molecular mechanisms underlying the anaerobic repression and the iron availability-dependent regulation have been well documented, the mechanism underlying the glucose repression is still not clear. Although CRP and Cra are known to be the key regulators of catabolite repression, they had been dismissed from the glucose repression of the *sdhCDAB* operon, although a putative CRP-binding site was proposed to be located on the *sdhC* promoter region ([@b7]). Through a series of genetic analyses to identify the regulator gene(s) involved in the glucose repression of the *sdhCDAB* operon, it was reported that the EIICB^Glc^ protein acts as a crucial mediator in the glucose repression ([@b10]). Recently, it has been shown that the dephospho-form of EIICB^Glc^ can sequester the global repressor Mlc through the direct protein--protein interaction and induce the expression of the Mlc regulon including the genes encoding PTS proteins ([@b11]--[@b13]). Although Takeda *et al*. ([@b10]) identified *mlc* as the gene responsible for the multicopy effect on the glucose repression of the *sdhCDAB* operon, they concluded that the single copy *mlc* gene on the chromosome is not directly involved in the mechanism of glucose repression of the operon.

In this study, we re-investigated regulation of the *sdhCDAB* expression by glucose and the PTS to elucidate the mechanism underlying the glucose repression. We conclude that the general carbon catabolite repression regulator CRP directly mediates the glucose repression of the *sdhCDAB* operon in a cAMP-dependent manner.

MATERIALS AND METHODS
=====================

Materials
---------

Cyclic AMP and orthonitrophenyl-β-[d]{.smallcaps}-galactopyranoside (ONPG) were obtained from Sigma. RNA polymerase saturated with σ^70^, \[γ-^32^P\]ATP and \[α-^32^P\]CTP were purchased from Amersham Biosciences. Nucleotide triphosphates were from MBI Fermentas. The cycle sequencing kit was from Epicentre Technologies (Madison, WI).

Bacterial strains, plasmids and growth conditions
-------------------------------------------------

The bacterial strains and plasmids used in this study are listed in [Table 1](#tbl1){ref-type="table"}. To generate the isogenic *arcA*, *crr*, *ptsG, mlc, crp* and *cya* deletion mutants, the indicated alleles were introduced into parental strain TSDH00 by P1 transduction ([@b14]). Luria--Bertani broth (LB) medium was used for the routine growth of bacteria unless otherwise indicated. If necessary, media were supplemented with sugars (40 mM). Antibiotics were used at the following concentrations: ampicillin, 100 µg/ml; kanamycin, 20 µg/ml; chloramphenicol, 30 µg/ml and tetracycline, 25 µg/ml.

To construct pHisEIIB, in which expression of the EIIB domain (the cytosolic domain of EIICB^Glc^) tagged with 6 histidines at its N-terminus (His-EIIB) is under the control of the pRE1-vector system ([@b15]), the pJHK plasmid ([@b12]) was digested with NdeI and BamHI, and the fragment encoding the EIIB domain was cloned into pRE-His-Tag ([@b16]).

To construct pBRcrp, in which *crp* expression is under the control of its own promoter, the sequence covering the *crp* promoter and coding regions was amplified by PCR using a mutagenic primer to create a PstI site (underlined) 316 nt upstream of the *crp* start codon (5′-CCC TTC GAC CCA [CTG CAG]{.ul} TCG CGC TTG CAT-3′) and a reverse primer located 256 nt downstream of the TAA stop codon (5′-GCG ACG CAC CAA TGA TTA AGC GTT TGA TGA AAA-3′). An SspI site is located 194 nt downstream of the stop codon in this PCR product and the 1137 bp PCR product digested with PstI and SspI was cloned into vector pBR322.

To construct pTSDHpro used as the supercoiled template for assay of *in vitro* transcription from the *sdhC* promoter, the DNA fragment covering from the position −183 to +209 relative to the transcription start site of *sdhC* ([@b9]) was amplified by PCR using SdhF1 containing an engineered EcoRI site and SdhP containing an engineered PstI site as the upstream and downstream primers, respectively ([Figure 1](#fig1){ref-type="fig"}). The PCR product digested with EcoRI and PstI was ligated into the corresponding cloning sites in front of the *rpoC* terminator in the plasmid pSA600 ([@b17]). Supercoiled template was prepared by Plasmid mini kit (Qiagen) in RNase-free condition for the *in vitro* transcription assay.

Primer extension assay
----------------------

Primer extension reactions were carried out as described previously ([@b18]). Cells were grown to *A*~600~ of 0.5, and total *E.coli* RNA was purified using RNeasy mini kit (Qiagen) and resuspended in sterile distilled water. Purified \[γ-^32^P\]end-labeled primer SdhPex ([Figure 1](#fig1){ref-type="fig"}) was mixed with 30 µg of total cell RNA. The mixture was heated to 60°C and then allowed to cool to room temperature over a period of 1 h. After annealing, 50 µl of reaction solution was added, which contained 700 µM dNTPs, 10 mM MgCl~2~, 5 mM DTT, 20 mM Tris--HCl, pH 8.3 and 100 U of SuperscriptII reverse transcriptase (Invitrogen). After the mixture was incubated at 40°C for 70 min, 2 µl of 0.5 M EDTA was added into the reaction mixture and incubated at 37°C for 30 min. The DNA was precipitated and resolved on an 8 M urea, 5% polyacrylamide gel and visualized by autoradiography. The same primer was also used for sequencing the *sdhC* promoter region.

Construction of transcriptional *lacZ* fusions
----------------------------------------------

To prepare the *sdhC-lacZ* fusion plasmid pRS-sdh0, the DNA fragment covering from positions −312 to +450 relative to the transcription start site of *sdhC* was amplified by PCR using SdhF0 and SdhR containing an engineered BamHI site as the upstream and downstream primers, respectively ([Figure 1](#fig1){ref-type="fig"}). The PCR product digested with EcoRI and BamHI was ligated into the corresponding cloning sites of pRS415 ([@b19]) to generate the *sdhC-lacZ* operon fusion plasmid pRS-sdh0. Similarly, the *sdhC-lacZ* fusions pRS-sdh1, pRS-sdh2, pRS-sdh3 and pRS-sdh4 were constructed first by the PCR amplification method and subsequently cloned into EcoRI/BamHI-digested pRS415 after digestion with the same enzymes. The DNA fragments covering from positions −183 (pRS-sdh1), −126 (pRS-sdh2), −60 (pRS-sdh3) and +26 (pRS-sdh4) to +450 bp relative to the *sdhC* transcription start were amplified using oligonucleotides SdhF1, SdhF2, SdhF3 and SdhF4 containing the engineered EcoRI sites as the upstream primers, respectively, and SdhR as the downstream primer ([Figure 1](#fig1){ref-type="fig"}). To generate mutation in the CRP binding site (CGTGACCTGGATCACT to C[TCTG]{.ul}CCTGGA[CTG]{.ul}C[A]{.ul}, changed bases underlined), two sequential PCR steps were carried out. In the first round of PCR, the mutagenic primer SdhCRP1 (5′-GGT TTT ATC CTG AAC TGC AGT CCA GGC AGA GAT AAC AAC-3′) was used in combination with SdhF0 for the amplification of the 5′ region from the CRP binding site, while the mutagenic primer SdhCRP2 (5′-GTT GTT ATC TCT GCC TGG ACT GCA GTT CAG GAT AAA ACC -3′) was used in combination with SdhR for the amplification of the 3′ region. The two PCR products were combined and used as template in the second round of PCR with sdhF0 and SdhR as the upstream and downstream primers, respectively. The second round PCR product digested with EcoRI and BamHI was ligated into the corresponding cloning sites of pRS415 to generate pRS-sdh5. All the constructs were verified by DNA sequencing by the dideoxy method using an Applied Biosystems automated sequencer. The *sdhC-lacZ* fusions located on pRS-sdh0, pRS-sdh1, pRS-sdh2, pRS-sdh3, pRS-sdh4 and pRS-sdh5 were transferred onto λRZ5 ([@b20]) and then inserted into the MC4100 chromosome to generate TSDH00, TSDH10, TSDH20, TSDH30, TSDH40 and TSDH50, respectively, as described previously ([@b19]). Several independent lysogens were analyzed to obtain monolysogens.

β-Galactosidase assays
----------------------

Cells were grown to *A*~600~ of 1.0, and β-galactosidase activities were measured using permeabilized cells as described previously ([@b14]). Enzymatic activities are given in units of µmol ONPG hydrolyzed per min. Average values of at least four independent samples were determined.

Detection of EIICB^Glc^-interacting proteins
--------------------------------------------

*E.coli* GI698 harboring pHisEIIB was used for overexpression of His-EIIB. Cell culture and induction of protein overexpression was performed as described previously ([@b12]). Purification of His-EIIB was carried out using the BD TALON™ metal affinity resin (BD Biosciences) following the manufacturer\'s instructions. EIIB was purified as described previously ([@b12]). *E.coli* MG1655 and MG1655 *Δmlc* ([@b21]) cells grown in 500 ml of LB media were resuspended in the binding buffer (20 mM HEPES, pH 8.1 containing 200 mM NaCl and 5 mM imidazole) in the presence of 100 µg/ml phenylmethylsulfonyl fluoride. The cell suspensions disrupted by passing through a French press at 10 000 p.s.i. were centrifuged at 12 000 *g* for 15 min at 4°C, and the supernatant solutions were used as crude extracts. Each crude extract was used for the ligand fishing experiment to search for a protein(s) interacting with His-EIIB by employing the BD TALON™ metal affinity resin. Proteins specifically interacting with His-EIIB were analyzed by matrix-assisted laser desorption ionization time-of-flight mass spectrometry as described previously ([@b21]). Protein concentration was determined by the bicinchoninic acid protein assay (Pierce).

Gel mobility shift assay
------------------------

Gel mobility shift assays were performed essentially as described previously ([@b12]). DNA fragments covering the promoter regions of *sdhC* and *ptsG* (from −183 to +156 and −264 to +180, respectively, relative to their transcription start sites) were amplified by PCR and labeled with \[γ-^32^P\]ATP by using T4 polynucleotide kinase. The DNA binding reaction mixtures in the binding buffer contained 100 µM of cAMP, 1 nM of ^32^P-labeled DNA fragments and indicated amounts of CRP. The binding mixtures were incubated at room temperature for 10 min and analyzed by electrophoresis on 6% polyacrylamide gels in 0.5× TBE at room temperature for 90 min.

*In vitro* transcription
------------------------

Reactions were carried out as described previously ([@b11]) in a 20 µl total volume containing 20 mM Tris-acetate, pH 8.0, 150 mM potassium glutamate, 1 mM DTT, 3 mM MgSO~4~, 1 nM supercoiled DNA template pTSDHpro, 100 µM cAMP, 40 µg/ml BSA, 1 mM ATP, 100 µM each GTP and UTP, 10 µM CTP, 5 µCi of \[α-^32^P\]CTP (3000 Ci/mmol) and 0.2 U of *E.coli* RNA polymerase. CRP and phosphorylated ArcA were prepared as described previously ([@b21]) and added to the reaction as described in the legend to [Figure 6](#fig6){ref-type="fig"}. All components except nucleotides were incubated at 37°C for 10 min. Transcription was started by the addition of nucleotides containing 100 µg/ml of heparin and terminated after 30 min by adding 20 µl of formamide loading buffer. mRNA was electrophoresed on an 8 M urea, 5% polyacrylamide gel and visualized by autoradiography.

Western blot analysis
---------------------

The phosphorylation state of EIIA^Glc^ was determined according to the procedure developed by Takahashi *et al*. ([@b22]). Cell culture (0.2 ml at *A*~600~ = 1.0) was quenched by adding 20 µl of 10 M NaOH followed by vortexing for 10 s, and then 180 µl of 3 M sodium acetate (pH 5.2) and 1 ml of ethanol were added. Samples were chilled at −70°C for at least 15 min, thawed and centrifuged at 4°C. The pellet was rinsed with 70% ethanol and resuspended in 100 µl of the SDS sample buffer, and 20 µl of this solution was analyzed by 15% SDS--PAGE. Proteins were then electrotransferred onto immobilin-P (Millipore, MA) following the manufacturer\'s protocol and were detected with immunoblotting using antiserum against EIIA^Glc^ raised in mice as described previously ([@b5]). The protein bands were visualized by using the SuperSignal West Pico kit (Pierce) following the manufacturer\'s instructions. The amounts of phosphorylated EIIA^Glc^ were quantified by densitometric tracing of the film using Eagle Eye™ II and Eagle sight software version 3.2 (Stratagene). To detect the intracellular levels of CRP, growing cells were taken at *A*~600~ of 1.0 and total cellular proteins were analyzed by SDS--PAGE using a 15% polyacrylamide gel. Proteins were then electrotransferred onto immobilin-P and western blot analysis was carried out using polyclonal antibody raised in mice against CRP. The protein bands were visualized by using the SuperSignal West Pico kit (Pierce) following the manufacturer\'s instructions.

Measurement of intracellular cAMP concentrations
------------------------------------------------

Intracellular cAMP concentrations were measured as described previously ([@b23]) with some modifications after cells were grown to an *A*~600~ of 1.0. Cells from 1 ml culture were collected by centrifugation and resuspended in 500 µl of the cell lysis buffer provided with the cAMP enzyme immunoassay system (Amersham Biosciences). After boiling cell suspensions in lysis buffer for 15 min and centrifugation, the cAMP concentrations in supernatants were determined by using the kit. The average intracellular cAMP concentration was expressed in femtomoles per 10^9^ cells assuming an *A*~600~ of1.0 corresponds to 8 × 10^8^ cells/ml ([@b24]). Average values of four independent cultures were determined.

RESULTS
=======

Deletion of the glucose-specific PTS genes affects the glucose repression of *sdhCDAB* expression
-------------------------------------------------------------------------------------------------

Although CRP and Cra are well-characterized global transcription factors regulating carbon catabolite repression of more than 100 genes, they have been dismissed from the glucose repression of *sdhCDAB* expression ([@b7]). To elucidate the mechanism of *sdhCDAB* repression by glucose, we first tested whether the glucose repression occurs at the transcriptional level or post-transcriptionally. Expression from the *sdhC* promoter was monitored by primer extension assay of the total RNA extracted from *E.coli* MG1655 cells grown in the presence or absence of glucose. The level of the *sdhC* transcript from the cells grown in the absence of glucose was much higher than that of cells grown in the presence of glucose ([Figure 2](#fig2){ref-type="fig"}). Since this result indicated that the glucose effect on *sdhCDAB* occurs at the transcriptional level, we constructed a series of transcriptional *sdhC-lacZ* fusion strains. The strain TSDH00 contains a single copy of the *sdhC-lacZ* transcriptional fusion gene in which *sdhC* promoter region extends from −312 to +450 relative to the transcription start site ([Figure 1](#fig1){ref-type="fig"}). Growth in the presence of glucose caused ∼3.4-fold decrease in *sdhC-lacZ* expression when compared with growth without glucose ([Figure 3](#fig3){ref-type="fig"}) in agreement with the mRNA level determined by the primer extension assays in [Figure 2](#fig2){ref-type="fig"} and previous reports ([@b7],[@b10]). As the ArcA anaerobic repressor is known to serve as the major transcriptional regulator of the *sdhCDAB* operon, we monitored the effect of *arcA* deletion on the glucose repression of *sdhC-lacZ* expression. While deletion of the *arcA* gene resulted in increase of *sdhC-lacZ* expression as expected from the previous reports ([@b6],[@b7],[@b9],[@b10]), it did not show any remarkable effect on the glucose repression of *sdhC-lacZ* expression. As a previous study had shown that the glucose repression of *sdhC-lacZ* expression is *ptsG*-dependent ([@b10]), we tested the effect of the two glucose-specific PTS genes, *crr* and *ptsG* encoding EIIA^Glc^ and EIICB^Glc^, respectively, on *sdhC-lacZ* expression. Deletion mutations of *crr* and *ptsG* were transduced into the TSDH00 strain to generate strains TSDH02 and TSDH03, respectively, and β-galactosidase activities of these strains were measured. As shown in [Figure 3](#fig3){ref-type="fig"}, the glucose repression was negligible in the *crr* deletion mutant when compared with wild type: growth of the TSDH02 strain in LB with glucose resulted in only a marginal decrease (∼1.5 fold) of *sdhC-lacZ* expression when compared with that without glucose. Deletion of *ptsG* resulted in the complete loss of glucose repression of *sdhC-lacZ* expression in agreement with the previous study ([@b10]). Loss of glucose repression of *sdhC-lacZ* expression in TSDH02 and TSDH03 implies that the glucose-specific PTS proteins play crucial roles in the glucose repression of *sdhCDAB* expression.

In agreement with the previous study by Takeda *et al*. ([@b10]), the results in [Figure 3](#fig3){ref-type="fig"} demonstrate the complete loss of the glucose repression of *sdhC-lacZ* expression in *ptsG* mutant. It was previously shown that the induction of *ptsG* and *ptsHIcrr* expression by glucose was also *ptsG*-dependent, and various studies showed that Mlc is the repressor responsible for this glucose induction ([@b18],[@b25]--[@b28]). Further studies revealed that the dephospho-form of EIICB^Glc^ could sequester the global repressor Mlc through the direct protein--protein interaction and induce expression of the Mlc regulon ([@b11]--[@b13]). Thus, the simplest model that could account for the glucose repression of *sdhCDAB* expression and its dependence on *ptsG* was the existence of a transcription regulator interacting with EIICB^Glc^ and repressing the expression of the *sdhCDAB* operon in the presence of glucose. To search for a protein(s) interacting with EIICB^Glc^ and thus mediating the glucose repression of *sdhCDAB* expression, we carried out a ligand fishing experiment. When the crude extracts prepared from MG1655 and its isogenic *mlc* mutant were mixed with EIIB or 6His-tagged form of EIIB (His-EIIB) and subjected to pull-down assays using the BD TALON™ metal affinity resin, we could not find out any proteins other than Mlc that specifically interacted with the glucose-sensing EIIB domain of the *ptsG* gene product (data not shown). Although it is well established that Mlc is the global transcription repressor regulating expression of many genes in response to the presence of glucose, the possibility that Mlc may participate in the glucose repression of *sdhCDAB* expression was ruled out as the *mlc* null mutant, TSDH04, still exhibited the glucose repression of *sdhC-lacZ* expression ([Figure 3](#fig3){ref-type="fig"}), in agreement with a previous report ([@b10]).

Regulation of *sdhCDAB* expression by the CRP·cAMP complex
----------------------------------------------------------

Considering the fact that only Mlc, which is known to exist in a very limiting concentration in *E.coli* ([@b18],[@b25]), could be fished out from the crude extract of MG1655 using EIIB as bait (data not shown), we assumed that the glucose repression of the *sdhCDAB* operon might not involve any transcription regulators interacting with EIICB^Glc^ in *E.coli* and that the effect of *ptsG* on the glucose repression of *sdhCDAB* expression might be indirect.

To search for the *cis*-acting region(s) responsible for regulation of the glucose repression of the *sdhCDAB* operon, a series of single-copy transcriptional *lacZ* fusion constructs containing various promoter regions of *sdhC* were generated and introduced into the *E.coli* strain MC4100. The glucose repression of *sdhC* expression in TSDH00 and four different 5′ deletion constructs of *sdhC-lacZ* fusion, TSDH10, TSDH20, TSDH30 and TSDH40, was monitored in cultures grown aerobically in the presence or absence of glucose ([Figure 4](#fig4){ref-type="fig"}). Disruption of the upstream ArcA site centered at −205 bp relative to the transcription start site (the TSDH10 strain) modestly reduced the level of aerobic gene expression as previously reported ([@b9]), while deletion of the DNA region containing the ArcA site centered at −119 elevated the level of aerobic *sdhC-lacZ* expression (TSDH20 strain). Regardless of the changes in the aerobic *sdhC-lacZ* expression levels, both the promoter fusions TSDH10 and TSDH20 still exhibited the glucose repression of *sdhC-lacZ* expression to significant levels similar to wild-type TSDH00 ([Figure 4](#fig4){ref-type="fig"}). On the construct TSDH30, *lacZ* was fused to the region covering from −60 to +450 bp relative to the *sdhC* transcription start, and thus the presumed CRP-binding site centered at −79.5 ([@b29]) was deleted but it still retains the ArcA binding site centered at −28 ([@b9]). This construct resulted in the significant reduction of β-galactosidase activity and growth of the TSDH30 strain in LB with glucose resulted in only a marginal decrease (1.49 fold) of *sdhC-lacZ* expression when compared with growth without glucose ([Figure 4](#fig4){ref-type="fig"}). These results indicate that the factor mediating the glucose repression may bind to the region extending from −126 to −60 relative to the transcription start site of the *sdhC* promoter, where the presumed CRP-binding site is located ([@b29]) ([Figures 1](#fig1){ref-type="fig"} and [4](#fig4){ref-type="fig"}). Since it was reported that the *crp* deletion mutant cell still showed the glucose repression of *sdhC*-*lacZ* expression ([@b7]), it had been believed that a regulator other than CRP would be responsible for the glucose repression of *sdhCDAB* expression ([@b10]). The promoter deletion experiments in this study, however, led us to speculate that CRP may be the direct regulator of the glucose repression of *sdhCDAB* expression. Therefore, we mutated the putative CRP binding site centered at −79.5 to check whether it is directly involved in the glucose repression of *sdh* expression. TSDH50, which contains a single copy of the *sdhC-lacZ* transcriptional fusion gene with mutated CRP binding site (CGTGACCTGGATCACT to CTCTGCCTGGACTGCA), resulted in the significant reduction of β-galactosidase activity and almost complete loss of the glucose repression of *lacZ* expression similar to the TSDH30 strain ([Figure 4](#fig4){ref-type="fig"}). From these results, we concluded that the CRP binding site on the *sdhC* promoter region is directly involved in the glucose repression of *sdhCDAB* expression.

The involvement of CRP and cAMP on the glucose repression of *sdhC* expression was further investigated using two deletion mutants lacking either CRP or cAMP production. Cells of the *crp* mutant strain, SA2777, were used to generate an isogenic *crp* deletion mutant of the parental strain TSDH00 by P1 transduction. After *crp* deletion was confirmed by western blot analysis using anti-CRP polyclonal antibody in this strain, TSDH05 (data not shown), β-galactosidase activities were measured in TSDH05 cells grown in LB media in the presence and absence of glucose. Contrary to the previous report, the glucose repression was completely abolished in this mutant strain (compare data for the *crp* mutant with wild type in [Figure 3A and B](#fig3){ref-type="fig"}). The *sdhC-lacZ* expression of TSDH05 grown in LB was even lower than that of wild-type cells grown in the presence of glucose, indicating that CRP is directly involved in the regulation of *sdhCDAB* expression. To determine whether the glucose repression of *sdhC*-*lacZ* expression is dependent on cAMP, an isogenic *cya* deletion mutant of TSDH00 was also generated by P1 transduction from the CA8000Δ*cya* strain ([@b30]). The *sdhC-lacZ* expression in this mutant strain TSDH06 showed a similar pattern with that of TSDH05 and was not affected by the presence of glucose (*cya* mutant in [Figure 3](#fig3){ref-type="fig"}). From these results, we concluded that the CRP·cAMP complex is one of the major transcriptional regulators of the *sdhCDAB* operon and it is directly involved in the glucose repression of *sdhCDAB*.

To confirm the direct involvement of CRP and cAMP in the glucose repression of the *sdhCDAB* operon, we tested the effect of episomally expressed CRP and cAMP added in the medium on *sdhC-lacZ* expression in the two mutant cells. The genomic DNA fragment containing the *crp* gene including its own promoter was cloned into the low copy number plasmid pBR322, and the product pBRcrp was transformed into the *crp* deletion mutant to see whether the glucose repression phenotype is recovered. The episomal expression of CRP increased the *sdhC-lacZ* expression in TSDH05 cells and the TSDH05 cells transformed with pBRcrp showed the glucose-dependent repression of *sdhC*-*lacZ* expression ([Figure 5A](#fig5){ref-type="fig"}). The *sdhC-lacZ* expression of TSDH05 cells harboring pBRcrp grown in the absence of glucose showed ∼1.8-fold higher β-galactosidase activity than that of cells grown in the presence of glucose, while TSDH05 cells harboring pBR322 showed the lower β-galactosidase activity regardless of the presence of glucose. These results suggest that elimination of the glucose repression of *sdhCDAB* expression in TSDH05 resulted from the failure of activation of gene expression by CRP. Inducibility of the *sdhC* promoter by cAMP was also investigated in the *cya* mutant strain ([Figure 5B](#fig5){ref-type="fig"}). The *sdhC-lacZ* expression level in TSDH06 cells was not significantly changed during the cell growth (filled circles). When 1 mM of cAMP was added to the growth medium, however, the *sdhC-lacZ* expression of TSDH06 cells was increased to ∼3-fold within 1 h. These results support that intracellular cAMP production as well as *crp* expression plays a crucial role in the regulation of *sdhCDAB* expression.

The CRP·cAMP complex binds to the *sdhC* promoter and regulates transcription *in vitro*
----------------------------------------------------------------------------------------

To show the direct binding of the CRP·cAMP complex to the *sdhC* promoter *in vitro*, gel shift assays were carried out using purified CRP and the *sdhC* promoter fragment in the presence of cAMP. The results showed that CRP·cAMP specifically binds to the s*dhC* promoter ([Figure 6A](#fig6){ref-type="fig"}). As the amount of CRP added in the reaction mixture increased, the amount of the CRP--promoter DNA complex also increased. Binding affinity of the CRP·cAMP complex toward the *sdhC* promoter was comparable with that toward the *ptsG* promoter.

To investigate the effect of CRP·cAMP binding to the promoter on *sdhCDAB* transcription, the *in vitro* transcription assay was performed with a supercoiled DNA template (pTSDHpro) containing base pairs −183 to +209 relative to the transcription start site, covering the *sdhC* promoter and its CRP and ArcA binding sites. When RNA polymerase alone was present in the reaction, transcription from the *sdhC* promoter did not occur efficiently ([Figure 6B](#fig6){ref-type="fig"}, lane 1). The addition of CRP and cAMP, however, remarkably increased the promoter activity ([Figure 6B](#fig6){ref-type="fig"}, lanes 2--5). Most intriguingly, incubation of the reaction mixture with ArcA-P repressed the CRP-activated promoter activity in a dose-dependent manner ([Figure 6B](#fig6){ref-type="fig"}, lanes 6--8). The specificity of CRP·cAMP function in *sdhCDAB* transcription was confirmed by the consistent activity of *rep* that originates from replication origin of the DNA template regardless of the presence of CRP and ArcA-P. These data confirm that the CRP·cAMP complex affects the *sdhCDAB* transcription initiation and is directly involved in the glucose repression of *sdhCDAB* expression.

The level of phosphorylated EIIA^Glc^ correlates with the intracellular cAMP concentration and *sdhC-lacZ* expression
---------------------------------------------------------------------------------------------------------------------

It was reported that expression of *sdhC-lacZ* varied depending on the type of carbon source added in the medium ([@b7]). From the above results, it could be assumed that the different expression levels of *sdhC-lacZ* on various sugars might result from the change in the intracellular cAMP concentration depending on the type of carbon source. To verify this assumption, the relationship between the intracellular cAMP concentrations and β-galactosidase activities was determined in TSDH00 cells grown in LB with various carbon sources. β-Galactosidase activities of TSDH00 revealed the carbon source-dependent expression of *sdhC-lacZ* ([Figure 7A](#fig7){ref-type="fig"}). Growth with mannose, fructose or maltose did not affect the expression level of *sdhC-lacZ*, while *N*-acetylglucosamine and galactose showed the similar effect with glucose on *sdhC-lacZ* expression. To investigate the effect of cAMP on *sdhC*-*lacZ* expression, the levels of intracellular cAMP were also measured ([Figure 7A](#fig7){ref-type="fig"}). The intracellular cAMP level in TSDH00 cells decreased when glucose was added to the medium, in agreement with the previous reports \[reviewed in ([@b1])\]. The intracellular cAMP level in cells grown on glucose, *N*-acetylglucosamine or galactose was lower than that in cells grown on mannose, fructose or maltose. The result showed that carbon source-dependent expression of *sdhC-lacZ* is in accordance with the intracellular cAMP concentration. Although the mechanism for the regulation of the intracellular cAMP level is not fully understood, a popular model for the regulation of adenylate cyclase activity is that phosphorylated EIIA^Glc^ stimulates adenylate cyclase activity and increases the intracellular cAMP concentration ([@b1]). Therefore, we measured the level of EIIA^Glc^ phosphorylation in the cells grown with various carbon sources by western blot analysis according to the procedure developed by Takahashi *et al*. ([@b22]) as described under 'Materials and Methods' ([Figure 7B](#fig7){ref-type="fig"}). It is well established that phosphorylated EIIA^Glc^ migrates slower than the dephosphorylated form on an SDS--polyacrylamide gel ([@b22]). The data in [Figure 7A and B](#fig7){ref-type="fig"} show that there is a general correlation between the level of EIIA^Glc^ phosphorylation and the intracellular cAMP concentration in the cells grown on each carbon source: the level of phosphorylated EIIA^Glc^ in cells grown with glucose, *N*-acetylglucosamine or galactose was lower than that in cells grown with mannose, fructose or maltose ([Figure 7B](#fig7){ref-type="fig"}). Taken together with above results, this result led us to the conclusion that the different phosphorylation state of EIIA^Glc^ on each sugar reflects the different cAMP concentration in the cell, and consequently the different *sdhCDAB* expression level depending on the type of carbon source added to the medium. From these facts, it could be predicted that the *ptsG* gene plays an indirect role and the *crr* gene product is the major determinant on the glucose repression of *sdhC* expression. It could be assumed that the level of EIIA^Glc^ phosphorylation may be unaffected by glucose in the *ptsG* mutant because EIIA^Glc^ cannot pass the phosphate group on to EIICB^Glc^. To verify this, we measured the level of EIIA^Glc^ phosphorylation in *ptsG* cells. As shown in [Figure 7C](#fig7){ref-type="fig"}, glucose in the growth medium did not affect the phosphorylation state of EIIA^Glc^ in the *ptsG* mutant cells. Based on these results, it is assumed that the loss of glucose repression of *sdhCDAB* expression in the *ptsG* mutant results from the lack of glucose-dependent regulation of the EIIA^Glc^ phosphorylation state in the mutant that affects the level of intracellular cAMP.

DISCUSSION
==========

It was reported that activities of *E.coli* TCA cycle enzymes such as succinate dehydrogenase are remarkably reduced during anaerobiosis and in the presence of glucose in the medium almost 40 years ago ([@b31]). The recent studies in the transcriptomic and proteomic levels also revealed that the genes involved in the TCA cycle are strongly repressed by glucose and/or anaerobiosis ([@b32]--[@b34]). While the mechanism underlying the anaerobic repression of *sdhCDAB* was well documented in previous studies ([@b7],[@b9]), the mechanism of the glucose repression of *sdhCDAB* expression still remains as a puzzling issue.

Although CRP was excluded from the regulatory circuit of *sdhCDAB* expression ([@b7]), several reasons prompted us to re-consider the CRP·cAMP complex as the direct mediator of the glucose repression of *sdhCDAB*: (i) the CRP·cAMP complex has been established as the major regulator of the glucose-mediated carbon catabolite repression of more than 100 genes ([@b1]); (ii) a putative CRP-binding site was proposed to be located on the *sdhC* promoter region ([@b29]) ([Figure 1](#fig1){ref-type="fig"}), although binding of CRP to the promoter has never been demonstrated; (iii) we could not find any transcription regulators other than Mlc that interact with the glucose-sensing EIIB domain of the *ptsG* gene product (data not shown), while it was shown that the *ptsG* gene acts as a crucial mediator of the glucose repression of the *sdhCDAB* operon ([@b10]). Furthermore, the *mlc* mutant still showed the glucose repression of *sdhCDAB* ([@b10]) ([Figure 3](#fig3){ref-type="fig"}); (iv) in a previous review, it was proposed that catabolite repression of the *sdhCDAB* operon is controlled presumably by the CRP·cAMP complex ([@b35]). (v) Finally, recent reports on the transcriptome analyses of the *crp* mutant using microarray techniques indicated that expression of the *sdhCDAB* operon was affected by deletion of the *crp* gene ([@b36],[@b37]). It was proposed that the *sdhCDAB* operon might actually be regulated by the CRP homologue Fnr *in vivo* ([@b37]), based on the facts that Fnr has been shown to regulate *sdhCDAB* expression in response to anaerobiosis ([@b7]), the consensus sequence for Fnr is similar to that for CRP, and both proteins can bind to the DNA site for the other protein ([@b38]).

From the results in this study, it is evident that CRP is directly involved in the regulation of *sdhCDAB* expression and the glucose repression of *sdhCDAB* occurs in a cAMP-dependent manner. Genetic studies using *cya* and *crp* mutants and the *sdhC-lacZ* fusion strain harboring the mutated *crp* binding site on the *sdhC* promoter region suggest that both cAMP and CRP are required for *sdhCDAB* expression and its glucose repression ([Figures 3](#fig3){ref-type="fig"}--[5](#fig5){ref-type="fig"}). *In vitro* studies demonstrate binding of CRP to the *sdhC* promoter and activation by the CRP·cAMP complex of *sdhC* transcription ([Figure 6](#fig6){ref-type="fig"}). Furthermore, the phosphorylation level of EIIA^Glc^ in cells grown with different carbon sources correlates with the intracellular concentration of cAMP and the *sdhC-lacZ* expression level ([Figure 7](#fig7){ref-type="fig"}). It was previously reported that the phosphorylation level of EIIA^Glc^ is dependent on the type of carbon source in the medium ([@b39]). Although no biochemical evidence has been provided, it is generally believed that the phosphorylated form of EIIA^Glc^ stimulates adenylate cyclase activity ([@b1]). In the presence of glucose, *N*-acetylglucosamine or galactose in the medium, the level of the phospho-form of EIIA^Glc^ decreased ([Figure 7B](#fig7){ref-type="fig"}). This decrease seems to be responsible for reduced activity of adenylate cyclase and reduced production of cAMP required to activate *sdhCDAB* expression after binding to its receptor protein CRP. Thus, we conclude that the CRP·cAMP complex mediates the glucose repression of the *sdhCDAB* operon. There still remains one question why the *ptsG* mutant exerts a more profound effect than mutation of *crr* on the glucose repression of the *sdhCDAB* promoter ([Figure 3](#fig3){ref-type="fig"}), that is in conflict with our conclusion that the *crr* gene product EIIA^Glc^ is the major regulator in orchestrating glucose repression of the *sdhCDAB* promoter. One possibility for this conflict may be due to the pleiotropic effect of the *ptsG* and *crr* mutants on expression of many genes expected from the fact that both EIICB^Glc^ and EIIA^Glc^ interact with and regulate activities of many regulatory proteins ([@b1],[@b5],[@b11]--[@b13]). More studies need to be carried out to fully understand this question.

Under fully aerobic conditions, the TCA cycle in *E.coli* operates as an oxidative pathway that needs the activities of succinate dehydrogenase, encoded by *sdhCDAB*, and α-ketoglutarate dehydrogenase. In the presence of readily fermentable sugars and/or under anaerobic conditions, however, the TCA cycle hardly operates in an oxidative way because coupling of the pathway to terminal respiration is absolutely required to maintain the activities of the succinate dehydrogenase complex and α-ketoglutarate dehydrogenase complex that produce FADH~2~ and NADH, respectively. On the other hand, the reactions that make oxaloacetate, succinyl-coenzyme A and α-ketoglutarate are necessary because these intermediates are still required for the biosynthesis of amino acids and tetrapyrroles. Under these conditions, the TCA cycle is converted from an oxidative and cyclic into a reductive and branched pathway to solve the problem. In the reductive pathway, succinyl-coenzyme A is made by reversing the reactions between oxaloacetate and succinyl-coenzyme A, using the enzyme fumarate reductase instead of succinate dehydrogenase ([@b40]). Thus, the decreased *sdhCDAB* expression by carbon catabolite repression in the presence of glucose provides one of the mechanisms to maintain the TCA cycle in a reductive pathway, leading to accumulation of succinate and succinyl-coenzyme A ([@b41]). The *sdhCDAB* operon in this study is not the first example of genes encoding the TCA cycle enzymes whose expression are activated by CRP and repressed by ArcA and Fnr. The *acnB*, encoding one of the two aconitases differentially expressed in *E.coli*, has been shown to be regulated in the same way as the *sdhCDAB* operon ([@b42]). Intriguingly, expression of both *fumA* and *sdhCDAB* was recently shown to be down-regulated by the small RNA, RyhB ([@b8]). Expression of the *fumA* and *fumC* genes encoding two fumarase isozymes of the TCA cycle in *E.coli* was also shown to be subject to the glucose repression and require cAMP ([@b43]). Thus, decrease in the CRP·cAMP level in the presence of readily fermentable glucose seems to be responsible for the reduced expression of genes encoding enzymes necessary to maintain the TCA cycle in an oxidative pathway and conversion of the cycle into a reductive pathway.
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![Organization of the regulatory sites in the *sdhC* promoter region. The nucleotide sequence between −330 and +470 with respect to the transcription start site of the promoter is shown. Lines above the sequence indicate the three ArcA binding sites and one presumable CRP binding site on the *sdhC* promoter, and the transcription start point and the translation start codon are marked in boxes. The dashed arrows below the sequence indicate the oligonucleotides SdhF0, SdhF1, SdhF2, SdhF3, SdhF4, SdhPex, SdhP and SdhR, and engineered restriction sites are shown below the arrows. The transcriptional start site and ArcA binding regions were from the previous report ([@b9]).](gki978f1){#fig1}

![Primer extension analysis of the *sdhC* transcript indicates that the glucose repression occurs at the transcriptional level. Total RNA was isolated from *E.coli* MG1655 cells grown in LB medium or LB medium supplemented with 40 mM glucose under aerobic condition. Primer extension analysis was carried out as described under 'Materials and Methods.' Lanes C, T, A and G show the DNA sequencing reaction products from the corresponding region within the *sdhC* regulatory region using the same primer.](gki978f2){#fig2}

![Effect of glucose in the medium on *sdhC-lacZ* expression in the strain TSDH00 and its isogenic mutants. (**A**) Relative levels of *sdhC-lacZ* expression. TSDH00 (WT) and its indicated mutant derivatives, each carrying the *sdhC-lacZ* transcriptional fusion gene on their chromosome, were grown in LB medium or LB medium supplemented with 40 mM glucose under aerobic conditions, and β-galactosidase activities were measured as described under 'Materials and Methods.' The shaded and open bars indicate β-galactosidase activities in Miller units in cells grown in LB medium with and without glucose, respectively. Activities represent the average of at least four independent experiments. (**B**) Glucose repression of *sdhC-lacZ* expression presented as the ratio of β-galactosidase activities in cells grown in LB to those in cells grown in LB + glucose.](gki978f3){#fig3}

![5′ Deletion analysis of the *sdhC* promoter region. Each construct was inserted into the MC4100 chromosome and monolysogens were selected and grown in LB media with or without glucose to search for the *cis*-acting region(s) responsible for regulation of the glucose repression of the *sdhCDAB* operon. (**A**) 5′ Deletion constructs of the transcriptional *sdhC-lacZ* fusions. Four ArcA binding sites, one CRP binding site and the translation start site are schematically shown. Mutated CRP binding site on TDH50 is shown as hatched box. The numbers refer to the nucleotide positions relative to the transcription start site of *sdhC*. Effect of glucose on *sdhC* expression is presented on the right side of each construct as the ratio of β-galactosidase activities in cells grown in LB to those in cells grown in LB with glucose. (**B**) β-Galactosidase activities of 5′ deletion constructs of the *sdhC-lacZ* fusion. Cells harboring each fusion construct were aerobically grown in LB medium or LB medium supplemented with 40 mM glucose, and β-galactosidase activities were measured as described above. Values represent the average of at least four independent determinations ± SD.](gki978f4){#fig4}

![Restoration of *sdhC-lacZ* expression by the addition of cAMP and episomal expression of CRP in the *cya* and *crp* mutants, respectively. (**A**) Complementation of the *crp* mutation phenotype on *sdhC*-*lacZ* expression by episomally expressed CRP. The open bars represent the *sdhC-lacZ* expression in the TSDH05 (Δ*crp*) strain harboring pBRcrp grown in LB and the shaded bars represent that in LB supplemented with glucose (40 mM). The TSDH05 strain harboring pBR322 was used as a control. (**B**) Addition of cAMP in growing medium increases the expression of *sdhC-lacZ* in *cya* mutant cells. Freshly grown TSDH06 (Δ*cya*) cells were inoculated into LB medium. After incubation for 2.5 h (marked with arrow) under aerobic condition at 37°C, cAMP (1 mM) was added to the medium (triangle), β-galactosidase activities were determined in cells taken at the indicated times and compared with those in cells grown without addition of cAMP (circle).](gki978f5){#fig5}

![CRP binds to the *sdhC* promoter and activates *sdhCDAB* expression *in vitro* in the presence of cAMP. (**A**) CRP binds to its target sites on the *ptsG* and *sdhC* promoters. ^32^P-labeled DNA probes containing the *ptsG* or *sdhC* promoter regions were mixed with the indicated CRP concentrations in the presence of 100 µM cAMP and then electrophoresed on 6% polyacrylamide gels. (**B**) The effect of CRP·cAMP and ArcA on *sdhCDAB* transcription *in vitro*. The supercoiled DNA template, pTSDHpro, was used for the *in vitro* transcription. The templates were preincubated with RNA polymerase and CRP and/or ArcA as described under 'Materials and Methods.' The reaction was started and stopped by the addition of NTP solution containing heparin and loading dye, respectively, and analyzed on a 5% polyacrylamide gel containing 8 M urea. Lanes 2--5 contain 5, 10, 20 and 40 nM CRP in the reaction, respectively; lanes 6--8 contain 100, 200 and 400 nM ArcA with 40 nM CRP in the reaction, respectively. The transcripts from the plasmid origin of replication (106/107 nt) are marked as *rep*. The 248 nt transcript from *sdhC* promoter is indicated.](gki978f6){#fig6}

![The phosphorylation level of EIIA^Glc^ correlates with the intracellular cAMP concentration and the *sdhC-lacZ* expression level. (**A**) Samples from exponentially growing cultures of the TSDH00 in LB or LB containing indicated sugars (40 mM) were taken and β-galactosidase activities (open bars) and cAMP concentrations (shaded bars) were determined as described above. (**B**) Using the same samples, the phosphorylation states of EIIA^Glc^ were determined by western blot analysis as described under 'Materials and Methods.' Amounts of the phosphorylated EIIA^Glc^ were quantitated using an image analyzer, and ratios compared with the sample from cells grown in LB are shown below the protein bands. (**C**) Western blot analysis indicates that the phosphorylation state of EIIA^Glc^ is not affected by the presence of glucose in the *ptsG* mutant. Ratios of the amount of phosphorylated EIIA^Glc^ compared with the sample from wild-type cells grown in LB are indicated below the protein bands.](gki978f7){#fig7}
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Bacterial strains and plasmids used in this study

  Strain or plasmid   Genotype or description                                                                       Source or reference
  ------------------- --------------------------------------------------------------------------------------------- ---------------------
  Strains                                                                                                           
      MG1655          Wild-type *E.coli*                                                                            ([@b44])
      MC4100          F-*relA1 araD139(argF-lac)* U169 *rpsL150 flb5301 deoC1 ptsF25 rbsR thiA*                     ([@b45])
      ECL618          F9 *arcA2 zjj*::Tn*10*, Tet*^r^*                                                              ([@b46])
      MG1655Δ*mlc*    MG1655 *mlc::Tet^r^*                                                                          ([@b21])
      TP2865          F-*xyl argH1* Δ*lacX74 aroB ilvA* Δ*crr*, $\text{K}_{\text{m}}^{\text{r}}$                    ([@b47])
      SR702Δ*ptsG*    *araD139 argF-lacU169rpsL150 thiA1 relA1 flbB5301 deoC1 ptsF25 rbsR suhX1 ptsG::cat*, Cm^r^   ([@b5])
      YJ2004          W3110 *lacU169 gal490 CI857 (cro-bioA) mlc::*Tet^R^                                           ([@b21])
      SA2777          F-*his rpsL relA* Δ*crp*, Cm^r^                                                               ([@b17])
      CA8000Δ*cya*    CA8000 Hfr *relA1 spoT1 thi-1 cya-1400*::$\text{K}_{\text{m}}^{\text{r}}$                     ([@b30])
      TSDH00          MC4100 λ \[Φ(*sdhC′*(−312/+450)*-′lacZ*)\]                                                    This work
      TSDH01          TSDH00 *ΔarcA*, Tet^r^                                                                        This work
      TSDH02          TSDH00 *Δcrr*, $\text{K}_{\text{m}}^{\text{r}}$                                               This work
      TSDH03          TSDH00 *ptsG*::*cat*, Cm^r^                                                                   This work
      TSDH04          TSDH00 *mlc*::Tet*^r^*                                                                        This work
      TSDH05          TSDH00 *crp*::*cat*, Cm^r^                                                                    This work
      TSDH06          TSDH00 *Δcya*, $\text{K}_{\text{m}}^{\text{r}}$                                               This work
      TSDH10          MC4100 λ \[Φ(*sdhC′*(−183/+450)*-′lacZ*)\]                                                    This work
      TSDH20          MC4100 λ \[Φ(*sdhC′*(−126/+450)*-′lacZ*)\]                                                    This work
      TSDH30          MC4100 λ \[Φ(*sdhC′*(−60/+450)*-′lacZ*)\]                                                     This work
      TSDH40          MC4100 λ \[Φ(*sdhC′*(+26/+450)*-′lacZ*)\]                                                     This work
      TSDH50          MC4100 λ \[Φ(*sdhC′*(−312/+450)*-′lacZ*)\], with mutated CRP binding site                     This work
  Plasmids                                                                                                          
      pRE-His-Tag     N-terminal 6 histidine in pRE1, Amp^r^                                                        ([@b16])
      pBR322          Cloning vector                                                                                ([@b48])
      PJHK            pRE1-based expression vector for EIIB                                                         ([@b12])
      pHisEIIB        pRE1-based expression vector for His-EIIB                                                     This work
      pBRcrp          *crp* in pBR322, Tet^r^                                                                       This work
      pSA600          Supercoiled plasmid containing *rpoC* terminator, Amp^r^                                      ([@b17])
      pTSDHpro        *sdhC* promoter region in pSA600                                                              This work
      pRS415          *lacZ lacY*^+^*lacA*^+^, Amp^r^                                                               ([@b19])
      pRS-sdh0        pRS415 \[Φ(*sdhC′*(−312/+450)*-′lacZ*)\], Amp^r^                                              This work
      pRS-sdh1        pRS415 \[Φ(*sdhC′*(−183/+450)*-′lacZ*)\], Amp^r^                                              This work
      pRS-sdh2        pRS415 \[Φ(*sdhC′*(−126/+450)*-′lacZ*)\], Amp^r^                                              This work
      pRS-sdh3        pRS415 \[Φ(*sdhC′*(−60/+450)*-′lacZ*)\], Amp^r^                                               This work
      pRS-sdh4        pRS415 \[Φ(*sdhC′*(+26/+450)*-′lacZ*)\], Amp^r^                                               This work
      pRS-sdh5        pRS415 \[Φ(*sdhC′*(−312/+450)*-′lacZ*)\] with mutated CRP binding site, Amp^r^                This work
